📊 PRVA Key Takeaways
Is Privia Health Group, Inc. (PRVA) a Good Investment?
Privia Health demonstrates strong revenue growth (+22.3% YoY) and robust free cash flow generation ($163.3M FCF), supported by a conservative balance sheet. However, profitability is deteriorating—net income declined 22.9% YoY despite revenue expansion—while operating margins remain dangerously thin at 1.6%, suggesting structural margin compression and weak pricing power in the healthcare services market.
Why Buy Privia Health Group, Inc. Stock? PRVA Key Strengths
- Strong top-line growth of 22.3% YoY indicating market demand and expansion
- Exceptional free cash flow conversion at 7.7% FCF margin with minimal capex requirements
- Conservative balance sheet with 0.04x debt-to-equity and $479.7M cash providing financial flexibility
PRVA Stock Risks: Privia Health Group, Inc. Investment Risks
- Net income declining 22.9% despite 22.3% revenue growth indicates severe margin compression and cost structure misalignment
- Operating margin of 1.6% and net margin of 1.1% leave virtually no buffer for operational disruptions or cost pressures
- ROE of 3.1% and ROA of 1.7% significantly underperform cost of capital, destroying shareholder value despite growth
Key Metrics to Watch
- Operating margin trend—must stabilize or expand to justify growth strategy
- Net income trajectory—confirm whether decline is temporary investment phase or structural limitation
- Operating cash flow sustainability—monitor whether FCF can be maintained as business scales
Privia Health Group, Inc. (PRVA) Financial Metrics & Key Ratios
💡 AI Analyst Insight
Privia Health Group, Inc. presents a mixed fundamental picture. Review the detailed metrics above to form your own investment thesis.
PRVA Profit Margin, ROE & Profitability Analysis
PRVA vs Services Sector: How Privia Health Group, Inc. Compares
How Privia Health Group, Inc. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Privia Health Group, Inc. Stock Overvalued? PRVA Valuation Analysis 2026
Based on fundamental analysis, Privia Health Group, Inc. has mixed fundamental signals relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Privia Health Group, Inc. Balance Sheet: PRVA Debt, Cash & Liquidity
PRVA Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Privia Health Group, Inc.'s revenue has grown significantly by 120% over the 5-year period, indicating strong business expansion. The most recent EPS of $0.19 reflects profitable operations.
PRVA Revenue Growth, EPS Growth & YoY Performance
PRVA Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $437.9M | $3.5M | $0.03 |
| Q2 2025 | $422.3M | $2.7M | $0.02 |
| Q1 2025 | $415.2M | $3.0M | $0.02 |
| Q3 2024 | $417.3M | $3.5M | $0.03 |
| Q2 2024 | $413.4M | $3.5M | $0.03 |
| Q1 2024 | $386.3M | $3.0M | $0.02 |
| Q3 2023 | $342.9M | $1.6M | $0.01 |
| Q2 2023 | $335.5M | $7.3M | $0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Privia Health Group, Inc. Dividends, Buybacks & Capital Allocation
PRVA SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Privia Health Group, Inc. (CIK: 0001759655)
📋 Recent SEC Filings
❓ Frequently Asked Questions about PRVA
What is the AI rating for PRVA?
Privia Health Group, Inc. (PRVA) has an AI rating of HOLD with 68% confidence, based on fundamental analysis of SEC EDGAR filings.
What are PRVA's key strengths?
Claude: Strong top-line growth of 22.3% YoY indicating market demand and expansion. Exceptional free cash flow conversion at 7.7% FCF margin with minimal capex requirements.
What are the risks of investing in PRVA?
Claude: Net income declining 22.9% despite 22.3% revenue growth indicates severe margin compression and cost structure misalignment. Operating margin of 1.6% and net margin of 1.1% leave virtually no buffer for operational disruptions or cost pressures.
What is PRVA's revenue and growth?
Privia Health Group, Inc. reported revenue of $2.1B.
Does PRVA pay dividends?
Privia Health Group, Inc. does not currently pay dividends.
Where can I find PRVA SEC filings?
Official SEC filings for Privia Health Group, Inc. (CIK: 0001759655) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is PRVA's EPS?
Privia Health Group, Inc. has a diluted EPS of $0.18.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is PRVA a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Privia Health Group, Inc. has a HOLD rating with 68% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is PRVA stock overvalued or undervalued?
Valuation metrics for PRVA: ROE of 3.1% (sector avg: 16%), net margin of 1.1% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy PRVA stock in 2026?
Our dual AI analysis gives Privia Health Group, Inc. a combined HOLD rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is PRVA's free cash flow?
Privia Health Group, Inc.'s operating cash flow is $163.4M, with capital expenditures of $113.0K. FCF margin is 7.7%.
How does PRVA compare to other Services stocks?
Vs Services sector averages: Net margin 1.1% (avg: 10%), ROE 3.1% (avg: 16%), current ratio 1.60 (avg: 1.5).